Development and validation of an LC-ESI-MS/MS method for the triple reuptake inhibitor indatraline enabling its quantification in MS Binding Assays
Crossref DOI link: https://doi.org/10.1007/s00216-014-8312-8
Published Online: 2014-12-02
Published Print: 2015-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Grimm, Stefanie H.
Höfner, Georg
Wanner, Klaus T.
Text and Data Mining valid from 2014-12-02